Handelsbanken Fonder’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-583	Closed	-$90K	–	1705
2022 Q1	$90K	Hold	583	–	–	﹤0.01%	1688
2021 Q4	$173K	Hold	583	–	–	﹤0.01%	1722
2021 Q3	$336K	Hold	583	–	–	﹤0.01%	1559
2021 Q2	$265K	Buy	+583	New	+$265K	﹤0.01%	1659